|
PHOT, URXE, SIRG, IMDS, ACLP, ALGF
Our Stocks to Watch tomorrow include Phototron Holdings Inc. (OTCBB: PHOT), Mustang Geothermal Corp. (OTCBB: URXE), Sierra Resource Group Inc. (OTCBB: SIRG), Imaging Diagnostic Systems Inc. (OTCBB: IMDS), AccelPath Inc. (OTCBB: ACLP) and Algae Farm (USA), Inc. (OTC: ALGF).
PHOTOTRON HOLDINGS INCORPORATED (OTCBB: PHOT)
"Up 208.82% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/PHOT.php
Phototron Holdings, Inc. is a progressive company with core holdings in innovative technology-based products and services for home gardening specialty markets including Stealth Grow LED brand LED grow lights and the Phototron single plant systems and accessories.
PHOT News:
No recent news for Phototron Holdings, Inc. (OTCBB: PHOT).
MUSTANG GEOTHERMAL CORPORATION (OTCBB: URXE)
"Up 81.82% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/URXE.php
Mustang Geothermal owns a 100% interest in 4,535 hectares of Federal geothermal leases in four project areas in the state of Nevada and holds 6,300 hectares of geothermal exploration concessions in seven areas (Banos del Inca, Paclla, Ninobamba, Atecata, Coline, and Condoroma South & Condoroma) in Peru
URXE News:
No recent news for Mustang Geothermal Corporation (OTCBB: URXE).
SIERRA RESOURCE GROUP INCORPORATED (OTCBB: SIRG)
"Up 33.80% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/SIRG.php
Sierra Resource Group Inc. is a U.S.-based exploration and mining company committed to the exploration, discovery and development of gold, silver, copper and other mineral resources. Sierra's primary asset is 90% ownership of the Chloride Copper Mine located near Kingman Arizona. The technical report, NI43-101, by Scott Wilson Roscoe Postle Associates March 10, 2006, estimates the Chloride Copper Mine contains 27,000,000 pounds of copper. The company is looking to expand throughout the Americas in the near future.
SIRG News:
June 1 - Sierra Resource Group to launch newly designed website
Sierra Resource Group, Inc. (OTCBB: SIRG) (the "Company" or "Sierra") announced today that it plans to launch its new website in June. Sierra engaged Miami based IT firm, Ingenium Solutions, LLC, to design and build the Company's new website, which will feature easy access to the latest Company news, descriptions of the Sierra's mining properties, resource reports and operations, and a separate section for investor information, including direct links to SEC filings and corporate governance policies. Ingenium is a well respected, total service IT firm that will be handling all IT work for Sierra in the future.
"We are very pleased with the design work of the firm, Ingenium Solutions, LLC, and the special attention its President Antonio Manueco gave to the project," said J. Rod Martin, Chief Executive Officer of Sierra.
Mr. Martin added: "Sierra intends to use its website www.sierragroupinc.com as a means of disclosing material information and for complying with its disclosure obligations under SEC Regulation FD. Such disclosures will be included on the Company's website under the headings 'Latest News'. Accordingly, investors should monitor such portions of the Company's website, in addition to following the Company's press releases, SEC filings and public conference calls and webcasts."
IMAGING DIAGNOSTIC SYSTEMS (OTCBB: IMDS)
"Up 66.67% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/IMDS.php
Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM® system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM®) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and shows the process of angiogenesis, which usually accompanies tumor growth. CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485. The Company is seeking FDA approval through the Premarket approval process.
IMDS News:
No recent news for Imaging Diagnostic Systems, Inc. (OTCBB: IMDS).
ACCELPATH INCORPORATED (OTCBB: ACLP)
"Up 25.49% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/ACLP.php
AccelPath provides technology solutions that play a key role in delivering information required for diagnosis of diseases and other pathologic conditions with and through its associated institutional pathologists. The medical institutions, with whom the Company partners, prepare comprehensive diagnostic reports of a patient’s condition and consult with referring physicians to help determine the most appropriate treatment. Such diagnostic reports enable the early detection of disease, allowing referring physicians to make informed and timely treatment decisions that improve their patients’ health in a cost-effective manner. The Company seeks out referring physicians and histology laboratories in need of high-quality pathology interpretations and manages HIPAA-compliant digital case delivery and reporting while developing comprehensive solutions for managing medical information.
ACLP News:
June 11 - AccelPath, Inc. Announces Dr. Keith J. Kaplan, M.D. Continues Role as Chairman on Company’s Medical Advisory Board
AccelPath, Inc. (OTCBB: ACLP) (“AccelPath” or the “Company”) announced that Dr. Keith J. Kaplan, M.D. continues his role as Chairman and active member of the Company’s Medical Advisory Board.
Keith J. Kaplan, MD is a pathologist and Chief Information Officer (CIO) of Carolinas Pathology Group (CPG), Celligent Diagnostics and Diligent Billing and Management. As CIO, Dr. Kaplan is responsible for all aspects of informatics strategies, operations, and projects and processes that encompass laboratory, healthcare and research information systems for Carolinas Pathology Group. Prior to joining CPG, Dr. Kaplan was a surgical pathologist at Mayo Clinic, Rochester, Minnesota and also held the academic post of associate professor of pathology of Mayo Medical School.
Dr. Kaplan is a graduate of Michigan State University, a graduate of Northwestern University Feinberg School of Medicine and completed residency training in anatomic and clinical pathology at Walter Reed Army Medical Center, Washington, DC. While at Walter Reed, Dr. Kaplan was named Resident of the Year and, in conjunction with the Armed Forces Institute of Pathology, Dr. Kaplan founded and directed the Army Telepathology Program. This Program connected 25 hospitals internationally for consultation via telepathology. Dr. Kaplan also served as the Medical Director and Consulting Pathologist of Laboratory Services at Keller Army Hospital in West Point, New York.
Dr. Kaplan is board certified in anatomic and clinical pathology. His subspecialty interests include gastrointestinal and hepatic pathology, cytopathology and pathology informatics as well as research interests in gastrointestinal and hepatobiliary pathology, hyperspectral imaging, image analysis and the use of Web 2.0 tools in pathology. He has authored over 60 peer-reviewed scientific articles, book chapters, editorials and scientific abstracts and frequently lectures at both national and international meetings on topics related to pathology informatics.
Dr. Kaplan currently serves as a member of the College of American Pathologists, American Society of Clinical Pathology and the American Society of Cytopathology as well as the American Pathology Foundation. He is also an executive board member of the Digital Pathology Association. Dr. Kaplan has previously served as a member of the College of American Pathologists Informatics Committee, Standards Committee, and Instrumentation Resource Committee and as co-chair of the American Telemedicine Association Telepathology Special Interest Group.
“We are very pleased with our collaborative relationship with Dr. Kaplan,” stated Shekhar Wadekar, AccelPath’s Chairman and Chief Executive Officer. “Dr. Kaplan’s expertise in the technical and medical components of digital telepathology (through his experiences at Walter Reed Army Medical Center / the Armed Forces Institute of Pathology, founding and directing the Army Telepathology Program, and industry experience as a practicing pathologist) provides us significant insights while we enhance our proprietary digital telepathology solutions. He will also be invaluable as we further apply those to existing pathology laboratories and related service providers.”
ALGAE FARM (USA) INCORPORATED (OTC: ALGF)
"Up 20.00% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/ALGF.php
ALGF is a development stage biotechnology developer of processes and systems that produce high yield, predictable, reliable, scalable and sustainable algal biomass, algae oil and residual biomass and in an indoor climate controlled environment. Algae Farm (USA), Inc. was founded in 1997 and is based in The Woodlands, Texas.
ALGF News:
June 13 - Algae Farm (USA) Patent Update
Algae Farm (USA), Inc. (OTC: ALGF) announces that it has received an office action from the United States Patent and Trademark Office ("USPTO") requesting an election of claims. ALGF filed a non-provisional utility application, "Device and Method for Production of Algae," on August 30, 2010. The application has been in review status since the initial filing date. ALGF's IP (Intellectual Property) counsel was contacted by the USPTO on June 1, 2012 and provided an option to elect to split the originally applied-for patent into two separate patents. ALGF has elected to pursue its process claims on the initial filing and will pursue a divisional application for its mechanical apparatus claims.
"Specifically, the Company will now have two separate patent applications, one for its industry-unique process to grow algae indoors, and the other for its mechanical apparatus. As a result of these actions, our expectation is to be awarded two patents instead of one. The average time to be granted a patent from the USPTO on a filing such as ours is roughly three years. We are very optimistic that we will now receive two patents instead of the single patent originally applied for; owning the two separate patents will add to our portfolio of immediately marketable intellectual property and dramatically enhance our ability to commercialize our technology and attract viable, strategic alliances and partnerships in the cosmetics, nutraceutical, bio-plastic and bio-fuel market sectors. By separating our applied-for patent into two, we will further ensure that both our methodological process and our unique mechanical production equipment used to produce our product remain exclusive to ALGF. Therefore, we will enjoy a significant market advantage over any competitors utilizing traditional outdoor production methods," said Rick Berman, President and CEO.
|
